AzTrials
AzTrials

PsychosocialPhase 1/2NCT01912014

Psychosocial Wellbeing Following Stroke

A Phase 1/2 study testing Psychosocial support and counselling in people with Psychosocial and Narrative, run by University of Oslo at 1 site in Norway.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The purpose of this feasibility study is to develop and initially test a dialogue-based psychosocial intervention aimed at promoting coping and psychosocial wellbeing following an acute stroke. The intervention is carried out by primary care registered nurses or other appropriate health professionals. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Psychosocial, Narrative, Coping
What is being tested?
Psychosocial support and counselling
Could I receive a placebo?
No, everyone receives an active treatment
How many people
25 participants
Where
1 siteNorway
Study dates
Jan 2007to Dec 2011
Phase
Phase 1/2
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • 18 years old or above
  • acute stroke
  • 4-8 weeks poststroke

Who cannot join

  • Other serious disease

Trial locations and contacts

1 site in 1 country.

Norway1 site
  • Oslo University hospital

    Oslo, Oslo

Other trials in Norway

About this study

Official title: Psychosocial Wellbeing Following Stroke: Developing and Testing a Psychosocial Nursing Intervention for Primary Care

The purpose of this feasibility study is to develop and initially test a dialogue-based psychosocial intervention aimed at promoting coping and psychosocial wellbeing following an acute stroke. The intervention is carried out by primary care registered nurses or other appropriate health professionals. The intervention included persons with and without aphasia.

Being tested
Psychosocial support and counselling
Keywords
stroke, psychosocial, intervention, quality of life
Medical subject headings
Narration, Stroke

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Psychosocial support and counsellingBehavioural

Study groups in NCT01912014
Study groupRoleWhat they receive
Psychosocial support and counsellingExperimentalThere is only one arm as this is a pilot and feasibility study.
Receives: Behavioral: Psychosocial support and counselling

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change from baseline in Stroke and Aphasia Quality of Life (SAQOL-39)

    Measured: baseline and 2 weeks after end of intervention

Secondary outcomes (1)
  1. Change from baseline in Stroke and Aphasia Quality of Life (SAQOL-39)

    Measured: baseline and 12 months after end of intervention

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted30 Jul 2013 (estimated)
  2. Study startJan 2007
  3. Primary completionApr 2011
  4. Study completionDec 2011

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase 1/2
Primary purpose
Health services research
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
25 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01912014
Sponsor's protocol ID
2.2007.37 (REK)
Other IDs
16369 (Social science data)
Status last verified
Jul 2013
First submitted
24 Jul 2013
Last updated
30 Jul 2013
Results posted
No
Data monitoring committee
Yes

Publications

  • Kirkevold M, Bronken BA, Martinsen R, Kvigne K. Promoting psychosocial well-being following a stroke: developing a theoretically and empirically sound complex intervention. Int J Nurs Stud. 2012 Apr;49(4):386-97. doi: 10.1016/j.ijnurstu.2011.10.006. Epub 2011 Nov 1.

    PubMed 22051438
  • Bronken BA, Kirkevold M. Between the lines: generating good qualitative data in studies involving persons with aphasia. ANS Adv Nurs Sci. 2013 Apr-Jun;36(2):E14-28. doi: 10.1097/ANS.0b013e318290200a.

    PubMed 23644268
  • Bronken BA, Kirkevold M, Martinsen R, Wyller TB, Kvigne K. Psychosocial well-being in persons with aphasia participating in a nursing intervention after stroke. Nurs Res Pract. 2012;2012:568242. doi: 10.1155/2012/568242. Epub 2012 Jul 22.

    PubMed 22888417
  • Kirkevold M, Martinsen R, Bronken BA, Kvigne K. Promoting psychosocial wellbeing following stroke using narratives and guided self-determination: a feasibility study. BMC Psychol. 2014 Feb 3;2(1):4. doi: 10.1186/2050-7283-2-4. eCollection 2014.

    PubMed 25566379

Questions about this trial

What is this clinical trial studying?

A Phase 1/2 study testing Psychosocial support and counselling in people with Psychosocial and Narrative, run by University of Oslo at 1 site in Norway.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 30 Jul 2013. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Norway. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this combined phase mean?

Phase 1 studies test a treatment in a small group of people for the first time or in a new way, mainly to check safety and find the right dose.

Phase 2 studies give the treatment to a larger group to see whether it has the intended effect and to keep checking safety.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change from baseline in Stroke and Aphasia Quality of Life (SAQOL-39) (time frame: baseline and 2 weeks after end of intervention). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT01912014, which also lists 4 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 30 Jul 2013.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in